Riskpilot← Back to searchSign inGet full accessBIOFORM AS
ASActiveOrg 981502949Skøelv, 9310 SørreisaManufacture of homogenised food preparations and dietetic food · NACE 1086Est. 200015 employeeswww.bioform.no
Revenue 2024
NOK 24,1M
+13% vs 2023
EBITDA margin
39.7%
+8% vs 2023
Equity ratio
78.8%
Financial strength
Net profit 2024
NOK 7,3M
-3% vs 2023
| Revenue | NOK 24,1M | +13% |
| EBITDA | NOK 9,6M | +8% |
| Net profit | NOK 7,3M | -3% |
| Total assets | NOK 32,6M | +58% |
| Equity | NOK 25,7M | +38% |
| Employees | 15 | — |
Legal name
BIOFORM AS
Org number
981502949
Legal form
Aksjeselskap
NACE code
1086 · Manufacture of homogenised food preparations and dietetic food
Founded
17. februar 2000
Share capital
NOK 700 000
Employees
15 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Produksjon av homogeniserte matprodukter, helsekost og diettmat, samt hva herved står i forbindelse med.
Address
Skøelv, 9310 Sørreisa
Website
www.bioform.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 7 471 | 14 996 | 12 616 | 21 268 | 24 112 |
| Staff expenses | −2 992 | −3 979 | −4 806 | −3 479 | −6 842 |
| EBITDA | −1 268 | 4 405 | 1 085 | 8 906 | 9 578 |
| Depreciation & amort. | −169 | −233 | −265 | −239 | −275 |
| EBIT | −1 438 | 4 173 | 820 | 8 667 | 9 303 |
| Net financials | −33 | −10 | −61 | −3 | 70 |
| Profit before tax | −1 470 | 4 163 | 759 | 8 664 | 9 373 |
| Tax | 114 | 914 | 4 | 1 118 | 2 069 |
| Net profit | −1 584 | 3 249 | 755 | 7 546 | 7 304 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 304 | 14 139 | 16 480 | 20 654 | 32 618 |
| Equity | 8 418 | 10 837 | 11 579 | 18 595 | 25 698 |
| Long-term debt | −14 | 0 | 0 | 0 | 2 000 |
| Short-term debt | 1 899 | 3 302 | 4 902 | 2 059 | 4 920 |
| Total debt | 1 885 | 3 302 | 4 902 | 2 059 | 6 920 |
EBITDA margin
39.7%
This company
15.8%
Market median
+151% vs market
20202024
Equity ratio
78.8%
This company
38.2%
Market median
+106% vs market
20202024
Return on equity
28.4%
This company
18.4%
Market median
+54% vs market
20202024
Net profit margin
30.3%
This company
8.1%
Market median
+274% vs market
20202024
Asset turnover
0.74×
This company
1.12×
Market median
-34% vs market
20202024
Debt / equity
0.27×
This company
0.62×
Market median
+56% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CS Deputy Member | Deputy Member | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Chairman | 2010 | |
| Chairman | 2010 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 77.14% | 77.14% | 2024 | |
| Company | 22.86% | 22.86% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ovesen Holding As
BIOFORM AS Board members of BIOFORM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cathrine Solstrand | Deputy Member | 0 companies |
| Trond Magne Solstrand | Deputy Chairman | 0 companies |
| Ole Alfred Rolf Ovesen | Chairman | 0 companies |